ArticleFrontiers in immunology2024

Poor prognostic factors of pharmacokinetic origin predict outcomes in inflammatory bowel disease patients treated with anti-tumor necrosis factor-α.

Elizabeth A Spencer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.